These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4725154)

  • 1. Single daily dose of diphenylhydantoin in children.
    Buchanan RA; Turner JL; Moyer CE; Heffelfinger JC
    J Pediatr; 1973 Sep; 83(3):479-83. PubMed ID: 4725154
    [No Abstract]   [Full Text] [Related]  

  • 2. Bio-availability and dissolution of three phenytoin preparations for children.
    Hodges S; Forsythe WI; Gillies D; Remington H; Cawood A
    Dev Med Child Neurol; 1986 Dec; 28(6):708-12. PubMed ID: 3817309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose oral phenytoin loading.
    Osborn HH; Zisfein J; Sparano R
    Ann Emerg Med; 1987 Apr; 16(4):407-12. PubMed ID: 3826809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationships in children.
    Borofsky LG; Louis S; Kutt H; Roginsky M
    J Pediatr; 1972 Nov; 81(5):995-1002. PubMed ID: 5086732
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma glucose and insulin responses to oral glucose with chronic diphenylhydantoin therapy.
    Cummings NP; Rosenbloom AL; Kohler WC; Wilder BJ
    Pediatrics; 1973 Jun; 51(6):1091-3. PubMed ID: 4710447
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phenytoin pharmacokinetics as a function of the preparation: capsules, commercial tablets and experimental tablets].
    Almaşu I; Leucuţa SE
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):283-93. PubMed ID: 2951833
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin.
    Serrano EE; Roye DB; Hammer RH; Wilder BJ
    Neurology; 1973 Mar; 23(3):311-7. PubMed ID: 4735181
    [No Abstract]   [Full Text] [Related]  

  • 8. One daily dose of diphenylhydantoin (DPH) to patients with epilepsy.
    Strandjord RE; Johannessen SI
    Acta Neurol Scand Suppl; 1972; 51():499-500. PubMed ID: 4514392
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioavailability of phenytoin from various pharmaceutical preparations in children.
    Manson JI; Beal SM; Magarey A; Pollard AC; O'Reilly WJ; Sansom LN
    Med J Aust; 1975 Oct; 2(15):590-2. PubMed ID: 1196223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One daily dose of diphenylhydantoin for patients with epilepsy.
    Strandjord RE; Johannessen SI; Halpern LM
    Epilepsia; 1974 Sep; 15(3):317-27. PubMed ID: 4527914
    [No Abstract]   [Full Text] [Related]  

  • 11. Diphenylhydantoin control of alcohol withdrawal seizures. Results of a controlled study.
    Sampliner R; Iber FL
    JAMA; 1974 Dec; 230(10):1430-2. PubMed ID: 4610196
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug interaction: diazoxide and diphenylhydantoin.
    Roe TF; Podosin RL; Blaskovics ME
    J Pediatr; 1975 Sep; 87(3):480-4. PubMed ID: 1165531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic and severe phenobarbital intoxication in a child treated with primidone and diphenylhydantoin.
    Wilson JT; Wilkinson GR
    J Pediatr; 1973 Sep; 83(3):484-9. PubMed ID: 4725155
    [No Abstract]   [Full Text] [Related]  

  • 14. Choreoathetosis and diphenylhydantoin intoxication.
    Shuttleworth E; Wise G; Paulson G
    JAMA; 1974 Nov; 230(8):1170-1. PubMed ID: 4479423
    [No Abstract]   [Full Text] [Related]  

  • 15. Diphenylhydantoin in children. Pharmacology and efficacy.
    Borofsky LG; Louis S; Kutt H
    Neurology; 1973 Sep; 23(9):967-72. PubMed ID: 4737688
    [No Abstract]   [Full Text] [Related]  

  • 16. Diphenylhydantoin metabolism in uremia.
    Letteri JM; Mellk H; Louis S; Kutt H; Durante P; Glazko A
    N Engl J Med; 1971 Sep; 285(12):648-52. PubMed ID: 5563477
    [No Abstract]   [Full Text] [Related]  

  • 17. The ineffectiveness of diphenylhydantoin in preventing febrile convulsions in the age of greatest risk, under three years.
    Melchior JC; Buchthal F; Lennox-Buchthal M
    Epilepsia; 1971 Mar; 12(1):55-62. PubMed ID: 4996854
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of phenytoin availability from pharmaceutical preparations].
    Leucuţa SE; Almaşu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):273-82. PubMed ID: 2951832
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diphenylhydantoin: study of plasmatic concentrations obtained by oral administration and of their antiarrhythmic effects].
    Chiche P; Laruelle P; Borgard JP; Chassang MF; Denizeau JP
    Coeur Med Interne; 1973 Oct; 12(4):621-31. PubMed ID: 4794332
    [No Abstract]   [Full Text] [Related]  

  • 20. A method for shifting from oral to intramuscular diphenylhydantoin administration.
    Wilder BJ; Serrano EE; Ramsey E; Buchanan RA
    Clin Pharmacol Ther; 1974 Sep; 16(3):507-13. PubMed ID: 4411662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.